Triple Therapy for High-Risk Older Adults Undergoing PCI? Not So Fast (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH
For older adults with atrial fibrillation and acute MI who undergo percutaneous coronary intervention (PCI), treatment with dual antiplatelet therapy (DAPT) plus warfarin (so-called triple therapy) appears to offer little cardiovascular benefit over DAPT alone — and …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Angioplasty | Atrial Fibrillation | Cardiology | Cardiovascular | Coronary Angioplasty | Coumadin | Heart | Percutaneous Coronary Intervention | Primary Care | Warfarin